期刊文献+

转铁蛋白修饰的喜树碱-树枝状高分子复合物的药动学研究 被引量:2

Study on tumor active targeting with Transferrin-PEG-PAMAM dendrimer-CPT conjugate
下载PDF
导出
摘要 目的探讨转铁蛋白修饰的主动靶向纳米载药复合物在大鼠体内的药动学行为。方法碱水解后采用HPLC法测定大鼠尾静脉给药后血浆中的药物浓度。结果经转铁蛋白修饰的主动靶向复合物能显著提高喜树碱在大鼠体内的半衰期及平均滞留时间,比未经转铁蛋白修饰的载药复合物的半衰期的平均滞留时间短。结论转铁蛋白-聚乙二醇-聚酰胺-胺树枝状分子-喜树碱复合物具有显著的长循环效果。关键词:聚酰胺-胺树枝状聚合物;转铁蛋白;聚乙二醇;喜树碱; Objective To explore the pharmacokinetics characteristic of transferrin modified PEG ylated polyamidoamine dendrimers(PEG-PAMAM) as the carrier for tumor targeting of the anticancer drug camptothecin(CPT) in rats.Methods CPT solution and PEG-PAMAM-CPT were used as control,transferrin modified PEG-PAMAM-CPT was injected via the tail vein.The plasma concentration of CPT in rats was determined by HPLC following alkaline hydrolysis.Results Transferrin modified PAMAM-PEG-CPT could enhance half-life and mean residence time comparing with that of CPT solution,but were relative shorter than that of CPT-PAMAM-PEG.Conclusion Transferrin modified PAMAM-PEG-CPT had a better long-circulating effect in rats.
出处 《肿瘤药学》 CAS 2012年第2期93-96,100,共5页 Anti-Tumor Pharmacy
基金 国家自然科学基金(30672543) 上海市科委基础重点项目(10JC1402202)
关键词 聚酰胺-胺树枝状聚合物 转铁蛋白 聚乙二醇 喜树碱 药动学 Poly(amidoamine) Dendrimer Transferrin Poly(ethylene glycol) Camptothecin Pharmacokinetics
  • 相关文献

参考文献10

  • 1Li Q.Y,Zu Y.G,Shi R.Z. Review Camptothecin:current perspectives[J].Current Medicinal Chemistry,2006,(17):2021-2039.
  • 2Joseph F P,Leonard B S. The camptothecin[J].Lancet,2003,(9376):2235-2242.
  • 3Schluep T,Cheng J.J,Khim K.T. Pharmacokenetics and biodistribution of the camptothecin-polymet conjugate IT-101 in rats and tumor-bearing mice[J].Cancer Che-motheapy Pharmcology,2006,(05):654-662.
  • 4Lalloo A,Chao P Y,Hu P. Pharmacokinetic and pharmcodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled de-livery of the camptothecin[J].Journal of Controlled Release,2006,(03):333-342.
  • 5Dennis O.S,Dilbir S.B,Valentino J.Stella. Plasma phar-macokinetics of the lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats[J].Pharmaceutical Research,1993,(10):1451-1457.
  • 6Gillies E R,Frechet J M J. Dendrimers and dendritic poly-mers in drug delivery[J].Drug Discovery Today,2005,(01):35-43.doi:10.1016/S1359-6446(04)03276-3.
  • 7Kojima C,Kono K,Maruyama K. Synthesis of polyam-idoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs[J].Bioconjugate Chemistry,2000,(06):910-917.
  • 8Gurdag S,Khandre J,Stapels S. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and-resistant cell lines[J].Bioconjugate Chemistry,2006,(02):275-283.
  • 9Li X.M,Ding L.Y,Xu Y.L. Targeted delivery of doxorubicin using stealth liposomes modified with transferring[J].International Journal of Pharmaceutics,2009,(1-2):116-123.
  • 10Hong M.H,Zhu S.J,Jiang Y.Y. Efficient tumor tar-geting of hydroxycamptothecin loaded PEGylated niosomes modified transferring[J].Journal of Controlled Release,2009,(02):96-102.

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部